Table II.
Good retention: ≥75% (n=1001) | Poor retention: <75% (n=250) | Unadjusted OR [95CI] | Wald test z value | p value | Adjusted ORb [95CI] | Wald test z value | p value | |
---|---|---|---|---|---|---|---|---|
Sex (male) | 717 (72) | 178 (71) | 1.02 [0.75, 1.38] | 0.134 | 0.89 | 1.25 [0.83, 1.87] | 1.070 | 0.29 |
Race (non-white) | 481 (48) | 115 (46) | 1.09 [0.82, 1.44] | 0.581 | 0.56 | 1.06 [0.77, 1.45] | 0.345 | 0.72 |
Age | ||||||||
<30 years | 287 (29) | 111 (44) | Ref | Ref | Ref | Ref | Ref | Ref |
30–40 years | 356 (36) | 88 (35) | 1.56 [1.14, 2.16] | 2.741 | 0.006 | 1.63 [1.16, 2.32] | 2.766 | 0.006 |
40–50 years | 257 (26) | 35 (14) | 2.84 [1.89, 4.35] | 4.923 | <0.0001 | 2.85 [1.83, 4.52] | 4.547 | <0.0001 |
≥50 | 101 (10) | 16 (6) | 2.44 [1.41, 4.46] | 3.063 | 0.002 | 2.37 [1.29, 4.56] | 2.697 | 0.007 |
Education (>8 years) | 535 (53) | 98 (39) | 1.78 [1.34, 2.37] | 4.001 | <0.0001 | 1.97 [1.43, 2.75] | 4.074 | <0.0001 |
Transmission route | ||||||||
Heterosexualc | 559 (56) | 131 (52) | Ref | Ref | Ref | Ref | Ref | Ref |
MSM | 400 (40) | 97 (39) | 0.97 [0.72, 1.30] | −0.229 | 0.83 | 0.80 [0.53, 1.19] | −1.112 | 0.26 |
IDU | 11 (1) | 4 (2) | 0.65 [0.22, 2.36] | −0.742 | 0.46 | 0.76 [0.22, 3.04] | −0.429 | 0.70 |
Unknown | 22 (2) | 16 (6) | 0.32 [0.17, 0.64] | −3.306 | 0.001 | 0.22 [0.10, 0.48] | −3.871 | 0.0001 |
Other | 9 (1) | 2 (1) | 1.29 [0.34, 8.42] | 0.067 | 0.73 | 1.33 [0.30, 9.28] | 0.340 | 0.74 |
Time-to-linkage ≤ 3mod | 514 (51) | 108 (43) | 1.39 [1.05, 1.84] | 2.300 | 0.02 | 1.17 [0.86, 1.59] | 1.013 | 0.30 |
ART Initiation | ||||||||
>24months post-linkage | 277 (28) | 100 (40) | Ref | Ref | Ref | Ref | Ref | |
3–24months post-linkage | 209 (21) | 51 (20) | 1.48 [1.01, 2.18] | 2.009 | 0.04 | 1.59 [1.03, 2.50] | 2.049 | 0.04 |
≤ 3months post-linkage | 515 (51) | 99 (40) | 1.88 [1.37, 2.57] | 3.935 | <0.0001 | 3.24 [1.89, 5.58] | 4.266 | <0.0001 |
Baseline CD4 cells/mm3e | ||||||||
> 350 | 437 (44) | 121 (48) | Ref | Ref | Ref | Ref | Ref | Ref |
≤ 350 | 518 (52) | 106 (42) | 1.35 [1.01, 1.81] | 2.043 | 0.04 | 0.68 [0.43, 1.08] | −1.624 | 0.10 |
Unknown | 46 (5) | 23 (9) | 0.55 [0.33, 0.96] | −2.147 | 0.03 | 0.30 [0.15, 0.63] | −3.237 | 0.001 |
AIDS-defining illnessf, g | 416 (42) | 102 (41) | 1.03 [0.78, 1.37] | 0.218 | 0.83 | 0.87 [0.60, 1.28] | −0.690 | 0.39 |
Depressionf | 158 (16) | 29 (12) | 1.43 [0.95, 2.22] | 1.653 | 0.10 | 1.50 [0.97, 2.40] | 1.761 | 0.08 |
Metabolic diseasef, h | 508 (51) | 102 (41) | 1.50 [1.13, 1.98] | 2.805 | 0.005 | 1.28 [0.94, 1.74] | 1.559 | 0.12 |
≥1 hospitalization during early care period | 183 (18) | 50 (20) | 0.89 [0.64, 1.28] | −0.624 | 0.53 | 0.76 [0.50, 1.15] | −1.329 | 0.18 |
Year of linkage [(IQR) per year increase] | 2007 (2005, 2009) | 2006.5 (2002, 2009) | 1.12 [1.07, 1.17] | 5.136 | <0.0001 | 1.12 [1.07, 1.18] | 4.546 | <0.0001 |
N(%), except where noted otherwise.
Adjusted model included: Sex, Race, Education, Transmission Route, Time-to-linkage, ART startdate, Baseline CD4, Baseline log HIV-1 RNA, AIDS-defining Illness, Depression, Metabolic Disease, Hospitalizations, Year of linkage.
Women with an unknown HIV transmission route (n=45) were categorized as heterosexual transmission, which did not affect our results (data not shown).
Time-to-linkage = date of linkage – date of HIV diagnosis.
First CD4 count result within first 3 months after date of linkage.
Diagnosed before the end of the early care period.
Center for Disease Control and Prevention (CDC) definition.
Diagnosed with at least one of the following: hypertension, diabetes, dyslipidemia, hypertriglyceridemia, or hypercholesterolemia.
MSM = men who have sex. IDU = intravenous drug user.